| 发明名称 |
Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin |
| 摘要 |
A controlled Release Pharmaceutical composition comprising an effective amount of Pravastatin and Fenofibrate, characterised in that the difference, in absolute value, between the times of maximal concentration (Tmax) of Pravastatin and Fenofibric acid is not less than 1.5 hours upon administration with food to humans. |
| 申请公布号 |
US2015037414(A1) |
申请公布日期 |
2015.02.05 |
| 申请号 |
US201012805021 |
申请日期 |
2010.07.07 |
| 申请人 |
Deboeck Arthur M.;Baudier Philippe;Vanderbist Francis;Sereno Antonio |
发明人 |
Deboeck Arthur M.;Baudier Philippe;Vanderbist Francis;Sereno Antonio |
| 分类号 |
A61K31/225;A61K31/519;A61K31/192 |
主分类号 |
A61K31/225 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An oral controlled release pharmaceutical composition comprising an effective amount pravastatin or a pharmaceutically acceptable salt thereof or both, and fenofibrate, said composition exhibiting a difference, in absolute value, between times of maximal concentration (Tmax) of pravastatin or salt thereof or both and fenofibric acid of not less than 1.5 hours upon administration with food to a human. |
| 地址 |
Gurabo PR US |
